Purpose

This study will examine the role of hereditary factors in different forms of severe combined immunodeficiency (SCID). Patients with immunodeficiencies may be eligible for this study. Candidates include: - Patients with diminished numbers of T cells or NK cells or both, or - Patients with normal T cell and NK cell numbers but diminished T cell, B cell, or NK cell function. Relatives of patients will also be studied. Participants will have blood samples collected for genetic analysis in studies related to SCID at the National Institutes of Health and other institutions.

Condition

Eligibility

Eligible Ages
Between 6 Months and 99 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Index cases to be included are those with diminished numbers of T cells and/or NK cells and/or B cells or other immune cells or those who have normal numbers of T cell, B cells, NK cells and other immune cells but diminished function of one or more immune cells. Relatives of affected individuals may also be studied - Patients (index cases): 6 months of age and older - Siblings: 6 months of age and older - Non-sibling relatives (biological parent, aunt, uncle or grandparent): 18 years or older

Exclusion Criteria

  • Patients with a known diagnosis - Patients with a particular immunological phenotype that is not of interest to the research conducted under this study. - Pregnancy or lactation - Adults with current decisional impairment

Study Design

Phase
Study Type
Observational
Observational Model
Family-Based
Time Perspective
Cross-Sectional

Arm Groups

ArmDescriptionAssigned Intervention
Non-sibling relative 18 years of age or older
Patients (index cases) Patients (index cases), 6 months of age or older
Siblings Siblings, 6 months of age or older

Recruiting Locations

National Institutes of Health Clinical Center
Bethesda 4348599, Maryland 4361885 20892
Contact:
For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
800-411-1222
ccopr@nih.gov

More Details

Status
Recruiting
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)

Study Contact

Warren J Leonard, M.D.
(301) 496-0098
wl2w@nih.gov

Detailed Description

The goal of this project is to identify the genetic basis of new forms of inherited immunodeficiency. The particular focus relates to cytokines such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 that share the common cytokine receptor (Gamma) chain, (Gamma c), and to molecules that are important for signaling or gene regulation in response to these cytokines, although other causes of inherited immunodeficiency are also encompassed.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.